Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Well of course everything is possible with stock that we trade!
It was election time! Ordering Elias down!
But this is quote from one of news!
"Fortunately, we are seeing an increase in requests and order flow since November 8, 2016, when a more med tech friendly administration was elected."
I'll take cheap ones and wait!
Added little more on this selloff
Not much but first loss in while.
It's out
What's your target? You are here since I got this stock several years ago.
In November CEO commented "As we previously reported, certain analysts have begun to take notice of our improved financial performance and position and have advised us that a company, such as ours, should expect a share price of between 18 to 25 times income. If our income trend continues, and their multiple advice is accurate, that could translate into a share price ranging from $0.50 to $0.70 per share."
http://www.prnewswire.com/news-releases/adm-tronics-ceo-comments-on-record-financial-results-300366531.html
Added little more today as well.
Very nice. Huge potential here. One of these days this stock will go to where really belongs
CEO buying!
Trump winning woke this baby up!!!!
I agree. I can wait. I'm here few years already
Yes I did see txhg. And on not much trades
Where do you think is headed?
Glad to have you back! Good luck.
Who knows!!!
It's still very low
We will see what happens. I'll wait and watch! Hope it gets some attention from investors. Thx for your input.
As soon as more investors finds out!
ADM Tronics CEO Comments On Record Financial Results 2016-11-21
NORTHVALE, N.J., Nov. 21, 2016 /PRNewswire/ -- Andre' DiMino, CEO of ADM Tronics Unlimited, Inc. (OTCQB: ADMT), a technology-based developer and manufacturer of innovative technologies and products, commented on ADMT's second quarter of fiscal year 2017 financial results reported on November 17,2016 in the Company's quarterly report on Form 10Q available at www.sec.gov.
ADMT CEO Andre' DiMino stated, "Since reconstructing our business model in 2013 we have booked eleven consecutive quarters of increased revenues and profits. Even more gratifying is that for the six months ended 9/30/16 we produced net income of $950,124 or $0.014 earnings per share, approaching the $0.017 earnings per share produced in our entire fiscal year ended 3/31/15. If this trend continues for the balance of this fiscal year, we believe we should produce income of approximately $0.028 per share for the current fiscal year on a fully diluted basis."
DiMino continued, "As we previously reported, certain analysts have begun to take notice of our improved financial performance and position and have advised us that a company, such as ours, should expect a share price of between 18 to 25 times income. If our income trend continues, and their multiple advice is accurate, that could translate into a share price ranging from $0.50 to $0.70 per share."
Replies:
That's what my thought was. $1 is my
bb72mo on 11/21/2016 10:13:59 AM
Report TOS
Question! Why some stocks don't show news on Ihub and they do on pr news
That's what my thought was. $1 is my long term target
I agree.
Time will tell. It might be whole loss or ?
He won!
Nice. Thank you!!!
Where is news?
I agree! Most of investors didn't even see the news what you mention! I had to google it when I saw your post!
Letter to ADMT Shareholders from Andre' Di Mino, CEO
NEWS PROVIDED BY
ADM Tronics Unlimited, Inc.
Oct 24, 2016, 15:40 ET
SHARE THIS ARTICLE
NORTHVALE, N.J., Oct. 24, 2016 /PRNewswire/ -- Andre' DiMino, CEO of ADM Tronics Unlimited, Inc. (OTCQB: ADMT) issued the following letter to shareholders.
October 24, 2016
Dear ADMT Shareholders:
At this fiscal year midpoint, I am pleased to update you on our progress.
First some background:
As you may know, the Affordable Care Act, commonly referred to as Obamacare, had a significant impact on the Medical Device industry, primarily due to the medical device excise tax and reduction in reimbursements for various medical procedures. In turn, this had a severe impact on our business plans and results in late 2012 and early 2013.
In response to the potentially devastating impact on our business, in early 2013 we reconstructed our business model and instituted a new plan of action. This had a significant positive effect, resulting in increased revenues and profits, as detailed in the following summary:
First Quarter
Fiscal Years Ended March 31,
FYE 2017
2013
2014
2015
2016
6/30/2016
Revenues
$1,580,841
$1,809,623
$2,850,548
$4,513,070
$1,377,431
% Increase
14.5%
57.5%
58.3%
Profit (Loss)
($537,130)
($225,214)
$358,790
$1,118,338
$521,230
% Difference
58.1%
259.3%
211.7%
These financial highlights are part of our SEC filings. I urge you to visit www.sec.gov for an in-depth view of our improved financial position.
Our balance sheet is strong and we anticipate becoming debt free by year end. We accomplished this without any equity or debt offerings for the past 10 years. We have achieved the above solely through internal growth. Management believes we can sustain continued growth over the remainder of this fiscal year ending March 31, 2017, and next fiscal year 2018.
Unfortunately, we believe the price of our common stock has not kept pace with the growth of our business. This could be partly due to our focus on generating increased revenues and our concerted effort to build a strong platform for our future growth. We believe that is now in place and ready to be leveraged.
Although increasing revenues and profits will always be Job #1, enhancing shareholder value has now become a top priority and we are preparing to launch the following initiatives:
1st)
To make a commitment to communicate more frequently with our shareholders, and the investing public, in general.
2nd)
To design a more vibrant and informative website to better reflect the company's position within our industry.
3rd)
To pursue avenues for greater exposure of our company and its future prospects to the investing public.
The above are just some of the initiatives we are planning for the future.
We thank our shareholders for your continued loyalty and support. We believe this should be a very exciting period for our company and our shareholders.
Sincerely,
Andre' DiMino
President and CEO
About ADMT
ADMT is a diversified, technology-based developer and manufacturer of innovative technologies and products. Its core competency is its ability to conceptualize a technology, bring it through development, into manufacturing and commercialization, all in-house. ADMT has three areas of activity: Medical Device Design, Engineering, Regulatory and Manufacturing Services; Proprietary Electronic Medical Devices; and Eco-Friendly, Water-Based Formulations. The Company's headquarters, laboratories, FDA-Registered medical device and manufacturing operations are in Northvale, NJ. ADMT's multi-disciplinary team of engineers, researchers and technologists utilize advanced technology infrastructure, such as 3-D prototyping, precision instrumentation and specialized software and peripherals, for the research, development and commercialization of diversified technologies. Additional information is available at the Company's websites - admtronics.com and concepttoquantity.com.
Yes. It's undervalued for sure. This will be couple bucks stock in years to come.
It'll go big for sure.
ADM Tronics Reports Fiscal Year 2016, Revenues Increase 58%
PR Newswire ADM Tronics Unlimited, Inc. Jul 13, 2016 3:37 PM
NORTHVALE, N.J., July 13, 2016 /PRNewswire/ -- ADM Tronics Unlimited, Inc. (ADMT), a technology-based developer and manufacturer of innovative medical technologies and proprietary products, today announced results for its fiscal year ended March 31, 2016.
Revenues for the year ended March 31, 2016 were $4,513,070 as compared to $2,850,548 for the last fiscal year ended March 31, 2016, an increase of 58%. Net income for the year was $1,118,338 or $0.02 per share which included a benefit for income taxes deferred of $857,000 as compared to $358,790 or $0.01 per share for the previous fiscal year. Complete financial results are available in the Company's Annual Report on Form 10K available at www.sec.gov.
Financial Highlights
Fiscal Year
Ended
March 31, 2015
Fiscal Year
Ended
March 31, 2015
Net Revenues
$4,513,070
$2,850,548
Cost of Sales
$1,915,901
$1,485,590
Gross Profit
$2,597,169
$1,364,958
Operating Expenses
$2,334,186
$1,115,009
Income (loss) from operations
$262,983
$249,949
Total other income
($1,645)
$108,841
Benefit for income taxes deferred
$857,000
-
Net income (loss)
$1,118,338
$358,790
Net income (loss) per common share
$0.02
$0.01
Weighted average shares of common stock outstanding - diluted
66,821,772
65,539,537
Andre' DiMino, ADMT President stated, "Our Company has continued our growth progress from last fiscal year with positive strides forward in both our own product development and client manufacturing over the course of the last 12 months, and we are pleased with the continued improved financial performance. We expect to maintain and increase revenue growth in our medical device engineering activities."
"The initiatives we instituted this past year have been successful. And, we are further expanding our efforts for the 2016 - 2017 fiscal year. We expect to see the financial contribution from those efforts continue in future quarters. Additionally, we are pursuing certain new technology opportunities that we believe can begin to further increase our revenues during the new fiscal year. This past fiscal year 2016 was a dynamic period of growth for our company, and we are excited about our future prospects," concluded DiMino.
About ADMT
ADM Tronics Reports Fiscal Year 2016, Revenues Increase 58%
PR Newswire ADM Tronics Unlimited, Inc. Jul 13, 2016 3:37 PM
NORTHVALE, N.J., July 13, 2016 /PRNewswire/ -- ADM Tronics Unlimited, Inc. (ADMT), a technology-based developer and manufacturer of innovative medical technologies and proprietary products, today announced results for its fiscal year ended March 31, 2016.
Revenues for the year ended March 31, 2016 were $4,513,070 as compared to $2,850,548 for the last fiscal year ended March 31, 2016, an increase of 58%. Net income for the year was $1,118,338 or $0.02 per share which included a benefit for income taxes deferred of $857,000 as compared to $358,790 or $0.01 per share for the previous fiscal year. Complete financial results are available in the Company's Annual Report on Form 10K available at www.sec.gov.
Financial Highlights
Fiscal Year
Ended
March 31, 2015
Fiscal Year
Ended
March 31, 2015
Net Revenues
$4,513,070
$2,850,548
Cost of Sales
$1,915,901
$1,485,590
Gross Profit
$2,597,169
$1,364,958
Operating Expenses
$2,334,186
$1,115,009
Income (loss) from operations
$262,983
$249,949
Total other income
($1,645)
$108,841
Benefit for income taxes deferred
$857,000
-
Net income (loss)
$1,118,338
$358,790
Net income (loss) per common share
$0.02
$0.01
Weighted average shares of common stock outstanding - diluted
66,821,772
65,539,537
Andre' DiMino, ADMT President stated, "Our Company has continued our growth progress from last fiscal year with positive strides forward in both our own product development and client manufacturing over the course of the last 12 months, and we are pleased with the continued improved financial performance. We expect to maintain and increase revenue growth in our medical device engineering activities."
"The initiatives we instituted this past year have been successful. And, we are further expanding our efforts for the 2016 - 2017 fiscal year. We expect to see the financial contribution from those efforts continue in future quarters. Additionally, we are pursuing certain new technology opportunities that we believe can begin to further increase our revenues during the new fiscal year. This past fiscal year 2016 was a dynamic period of growth for our company, and we are excited about our future prospects," concluded DiMino.
About ADMT
ADM Tronics Reports Fiscal Year 2016, Revenues Increase 58%
PR Newswire ADM Tronics Unlimited, Inc. Jul 13, 2016 3:37 PM
NORTHVALE, N.J., July 13, 2016 /PRNewswire/ -- ADM Tronics Unlimited, Inc. (ADMT), a technology-based developer and manufacturer of innovative medical technologies and proprietary products, today announced results for its fiscal year ended March 31, 2016.
Revenues for the year ended March 31, 2016 were $4,513,070 as compared to $2,850,548 for the last fiscal year ended March 31, 2016, an increase of 58%. Net income for the year was $1,118,338 or $0.02 per share which included a benefit for income taxes deferred of $857,000 as compared to $358,790 or $0.01 per share for the previous fiscal year. Complete financial results are available in the Company's Annual Report on Form 10K available at www.sec.gov.
Financial Highlights
Fiscal Year
Ended
March 31, 2015
Fiscal Year
Ended
March 31, 2015
Net Revenues
$4,513,070
$2,850,548
Cost of Sales
$1,915,901
$1,485,590
Gross Profit
$2,597,169
$1,364,958
Operating Expenses
$2,334,186
$1,115,009
Income (loss) from operations
$262,983
$249,949
Total other income
($1,645)
$108,841
Benefit for income taxes deferred
$857,000
-
Net income (loss)
$1,118,338
$358,790
Net income (loss) per common share
$0.02
$0.01
Weighted average shares of common stock outstanding - diluted
66,821,772
65,539,537
Andre' DiMino, ADMT President stated, "Our Company has continued our growth progress from last fiscal year with positive strides forward in both our own product development and client manufacturing over the course of the last 12 months, and we are pleased with the continued improved financial performance. We expect to maintain and increase revenue growth in our medical device engineering activities."
"The initiatives we instituted this past year have been successful. And, we are further expanding our efforts for the 2016 - 2017 fiscal year. We expect to see the financial contribution from those efforts continue in future quarters. Additionally, we are pursuing certain new technology opportunities that we believe can begin to further increase our revenues during the new fiscal year. This past fiscal year 2016 was a dynamic period of growth for our company, and we are excited about our future prospects," concluded DiMino.
About ADMT
ADMT REVENUES AND GROSS MARGINS
Revenues increased $1,662,522, or 58% from the prior year, which resulted from increases of $1,318,148 in the engineering segment, $10,141 in the electronics segment and $334,233 in the chemical segment. The increases in the chemical division and electronics division resulted from an increased customer base. The increase in engineering services was primarily the result of several projects for one customer.
The decrease in gross profit in the electronic segment and increase in gross profit in the chemical segment resulted from changes in the mix of products sold.
The increase in gross profit in the engineering segment resulted from better utilization of labor due to the increased revenue from new projects for one customer.
OPERATING INCOME (LOSS)
Income from operations for the years ended March 31, 2016 and 2015 was $262,983 and $249,949 respectively, an increase of $13,034 or 5%.
Selling, general and administrative expenses increased by $566,410, or 53%, from $1,073,342 to $1,639,752, mainly due to increased royalties and commissions of $80,801, and increased salaries and wages of $61,636, increased contract services of $223,460, increased professional fees of $32,525, increased computer expenses of $54,229, increased insurance expenses of $38,582, and increased bad debt of $45,165.
NET INCOME AND NET LOSS PER SHARE
Net income for the fiscal years ended March 31, 2016 and 2015 was $1,118,338 or $0.02 per share and $358,790 or $0.01 per share, respectively.
Report TOS
Report TOS
ADMT REVENUES AND GROSS MARGINS
Revenues increased $1,662,522, or 58% from the prior year, which resulted from increases of $1,318,148 in the engineering segment, $10,141 in the electronics segment and $334,233 in the chemical segment. The increases in the chemical division and electronics division resulted from an increased customer base. The increase in engineering services was primarily the result of several projects for one customer.
The decrease in gross profit in the electronic segment and increase in gross profit in the chemical segment resulted from changes in the mix of products sold.
The increase in gross profit in the engineering segment resulted from better utilization of labor due to the increased revenue from new projects for one customer.
OPERATING INCOME (LOSS)
Income from operations for the years ended March 31, 2016 and 2015 was $262,983 and $249,949 respectively, an increase of $13,034 or 5%.
Selling, general and administrative expenses increased by $566,410, or 53%, from $1,073,342 to $1,639,752, mainly due to increased royalties and commissions of $80,801, and increased salaries and wages of $61,636, increased contract services of $223,460, increased professional fees of $32,525, increased computer expenses of $54,229, increased insurance expenses of $38,582, and increased bad debt of $45,165.
NET INCOME AND NET LOSS PER SHARE
Net income for the fiscal years ended March 31, 2016 and 2015 was $1,118,338 or $0.02 per share and $358,790 or $0.01 per share, respectively.
Report TOS
LIQUIDITY AND CAPITAL RESOURCES
At March 31, 2016, we had cash and cash equivalents of $1,398,848 as compared to $216,395 at March 31, 2015. The increase of $1,182,453 was primarily the result of cash provided in operations in the amount of $935,211 and cash provided by financing activities of $275,000 offset by cash used by investing activities of $27,758. We expect to have enough cash to fund operations for the next twelve months. Our note payable to Kearny Federal Savings Bank of $96,966 on March 31, 2016, is secured and collateralized by restricted cash of $233,050. This note bears an interest rate of 2% above the rate for the savings account. The interest rate at March 31, 2016 was 2.15% per annum and is payable on demand.
Future Sources of Liquidity:
We expect our primary source of cash during fiscal 2017 to be net cash provided by operating activities. We expect that growth in profitable revenues and continued focus on new customers will enable us to continue to generate cash flows from operating activities.
If we do not generate sufficient cash from operations, face unanticipated cash needs or do not otherwise have sufficient cash, we may need to consider the sale of certain intellectual property which does not support the Company’s operations. In addition, we have the ability to reduce certain expenses depending on the level of business operation.
Based on current expectations, we believe that our existing cash of $1,398,848 as of March 31, 2016 and other potential sources of cash will be sufficient to meet our cash requirements. Our ability to meet these requirements will depend on our ability to generate cash in the future, which is subject to general economic, financial, competitive, legislative, regulatory and other factors that are beyond our control.
Although we expect available funds and funds generated from our operations to be sufficient to meet our anticipated needs for a minimum of 12 months, we may need to obtain additional capital to continue to operate and grow our business. Our cash requirements may vary materially from those currently anticipated due to changes in our operations, including our marketing and sales activities, product development, and the timing of our receipt of revenues. We do not have any material external sources of liquidity or unused sources of funds. Our ability to obtain additional financing in the future will depend in part upon the prevailing capital market conditions, as well as our business performance. There can be no assurance that we will be successful in our efforts to arrange additional financing on terms satisfactory to us or at all. Additionally, we will continue to reduce certain of our expenses in order to assist in meeting our capital n